Powered and Prepared for Your Next Label-Free Challenge With Dr. Helge Schnerr
As the global biopharmaceutical industry continues to grow, there is a need for innovative solutions that accelerate development and manufacturing workflows. Label-free protein analysis offers unique advantages for characterizing the biomolecular interaction kinetics of therapeutic candidates during this process. The Sartorius Octet® Label-Free Platform has become an industry leader for its bio-layer interferometry (BLI)-based systems for label-free, real-time analysis.
Recently, the platform has expanded to include the next-generation surface plasmon resonance (SPR)-based instrument, Octet® SF3, making Sartorius the only company to offer both label-free technologies to its customers.
In this episode of Teach Me in 10, we speak with Helge Schnerr, global campaign manager at Sartorius, about the motivation behind this move, the game-changing features on the SF3 and how it all translates to empowering scientists.
For more information, visit https://www.sartorius.com/octet-spr